| | Total patients, n (%) | | 40 (100%) |
| | Male gender, n (%) | 26 (65%) | | Age (years), median (IQR) | 59.5 (51.7; 66.7) |
| | Etiology of cirrhosis | Alcohol, n (%) | 25 (63%) | | NAFLD, n (%) | 11 (27%) | | Mixed (viral hepatitis and alcohol), n (%) | 4 (10%) |
| | Liver function and portal hypertension | Child-Pugh score, n (%) | A 19 (47%), B 18 (45%), C 3 (8%) | | MELD, median (IQR) | 13 (9; 17.8) | | D’Amico stages, n (%) | | | Stage 1 | 4 (10%) | | Stage 2 | 8 (20%) | | Stage 4 | 12 (30%) | | Stage 5 | 16 (40%) | | HVPG, mmHg (IQR) | 17 (11; 20) | | HVPG stages, n (%) | | | 6–9 mmHg | 6 (15%) | | 10–19 mmHg | 22 (55%) | | ≥20 mmHg | 12 (30%) |
| | Laboratory values, median | Sodium, mmol/l (IQR) | 138 (135; 139) | | Potassium, mmol/l (IQR) | 3.8 (3.6; 4.2) | | BUN, mg/dl (IQR) | 14 (11; 21) | | SCr, mmol/l (IQR) | 0.8 (0.7; 1.1) | | INR, median (IQR) | 1.4 (1.2; 1.7) | | Bilirubin, mg/dl (IQR) | 1.5 (1.3; 3.7) | | CRP, mg/l (IQR) | 8.4 (4.5; 18) | | Albumin, g/l (IQR) | 30 (24.5; 35) | | Thrombocytes, /nl (IQR) | 110 (87; 150.5) | | WBC, /nl (IQR) | 5.7 (4.2; 8.5) |
|
|
Note: Data are expressed as medians with interquartile ranges or as frequencies with percentages; BUN, blood urea nitrogen; SCr, serum creatinine, HVPG, hepatic venous pressure gradient; MELD, model for end-stage liver disease; WBC, white blood cell count; INR, international normalized ratio; CRP, C-reactive protein.
|
